Related Experiment Video
Updated: Aug 11, 2026

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
Published on: March 30, 2018
CD5- mantle cell lymphoma
Zach Liu1, Henry Y Dong, Wojciech Gorczyca
1IMPATH, New York, NY 10019, USA.
Insights
Mantle cell lymphoma (MCL) can lack CD5 expression, challenging diagnosis. Evaluating bcl-1 protein is crucial for identifying these CD5-negative MCL cases.
Area of Science:
- Hematology
- Oncology
- Pathology
Background:
- Mantle cell lymphoma (MCL) is typically characterized by B-cell antigen and CD5 expression, along with bcl-1 protein overexpression.
- Unusual presentations of bcl-1 positive and CD5 negative MCL pose diagnostic and management difficulties.
Purpose of the Study:
- To investigate cases of CD5-negative lymphoma with features consistent with MCL.
- To determine the diagnostic utility of bcl-1 expression in the absence of CD5.
Main Methods:
- Analysis of 25 cases (48 samples) of bcl-1 positive and CD5 negative lymphoma.
- Assessment of CD5 expression using flow cytometry and immunohistochemistry.
- Morphological evaluation for MCL features (centrocytic and blastic variants).
- Cytogenetic analysis including fluorescence in situ hybridization (FISH) for t(11;14) translocation.
Main Results:
- Twenty-five cases of bcl-1 positive, CD5 negative lymphoma were identified.
- Morphological features consistent with MCL were observed in 20 cases (centrocytic) and 5 cases (blastic variant).
- The characteristic t(11;14) translocation was confirmed in 8 of 11 cases by FISH and in 2 additional cases by cytogenetics.
Conclusions:
- Mantle cell lymphoma can present without CD5 expression.
- Immunohistochemical evaluation of bcl-1 or molecular genetic testing is essential for diagnosing MCL when CD5 is negative but clinical or morphological suspicion remains.
Abstract:
Mantle cell lymphoma (MCL) typically expresses B-cell antigens and CD5 and overexpresses bcl-1 protein. However, unusual cases of bcl-1+ and CD5-MCL have been observed, posing a practical challenge for correct diagnosis and management. We identified 25 cases (48 samples) of bcl-1+ and CD5- lymphoma. CD5 expression was assessed by flow cytometric analysis alone (1 case), immunohistochemical analysis alone (17 cases), or dual flow cytometric/immunohistochemical methods (7 cases). The morphologic features were consistent with MCL with centrocytic cytomorphology in 20 cases and blastic variant in 5 cases. The t(11;14) was confirmed in 8 of 11 cases by fluorescence in situ hybridization of paraffin-embedded tissue. Cytogenetic analysis revealed the t(11;14) within a complex karyotype in 2 additional cases. These data show that MCL may lack CD5 expression. Evaluation of bcl-1 expression by immunohistochemical analysis or molecular genetics may be indicated if MCL is suspected clinically or morphologically despite a lack of CD5 expression.
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
Lymphoid Cells and Tissues
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Primary Lymphoid Organs
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...

